Lumigan®
Bimatoprost is a synthetic prostamide analog used to reduce elevated intraocular pressure in glaucoma and ocular hypertension.
| Dosage Form | Ophthalmic Solution |
| Strength | 0.01%, 0.03% |
| Storage | Store at 2–25°C. |
| Category | Ophthalmics |
| Availability | Available for Transfer |
Open-angle glaucoma; ocular hypertension (reduction of elevated IOP).
Synthetic prostamide analog that increases aqueous humor outflow through both the uveoscleral and trabecular meshwork pathways, reducing intraocular pressure.
Each Burrard Pharmaceuticals technology transfer package for Bimatoprost includes comprehensive documentation and support:
Complete formulation with manufacturing parameters, excipient specifications, and process controls.
Validated methods for assay, impurities, dissolution, and stability-indicating analysis.
Market-ready regulatory dossier sections for a named territory, scoped per programme.
ICH-compliant stability studies (accelerated and long-term) with detailed protocols.
Scale-up procedures, batch records, equipment specifications, and in-process controls.
Direct advisory access to formulation scientists and regulatory specialists throughout transfer.
Scope and timing for the complete know-how package are confirmed in writing after a confidentiality agreement. Book a consultation to discuss your specific requirements.